In Supreme Court petition, Merck argues that FDA power shields against liability

A Merck & Co. appeal in the Fosamax liability litigation has drawn in the U.S. Solicitor General, and with its focus on the FDA's power to determine official drug labels, the outcome could reverbe…
Read the full story: FiercePharma: Pharma